Literature DB >> 10470051

No increase in demyelinating diseases after hepatitis B vaccination.

F Zipp, J G Weil, K M Einhäupl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10470051     DOI： 10.1038/12376

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

Review 1.  Demyelinating disease and hepatitis B vaccination: is there a link?

Authors:  T Jefferson; H Heijbel
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Vaccination safety update.

Authors:  Burkhard Schneeweiss; Michael Pfleiderer; Brigitte Keller-Stanislawski
Journal:  Dtsch Arztebl Int       Date:  2008-08-25       Impact factor: 5.594

Review 3.  [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Authors:  M Löbermann; B Handorn; A Winkelmann; E C Reisinger; H P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 4.  [Vaccination and multiple sclerosis].

Authors:  M Löbermann; A Winkelmann; E C Reisinger; U K Zettl
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 5.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

Review 6.  Drug treatment of pediatric chronic hepatitis B.

Authors:  Etienne Sokal
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage.

Authors:  S Hustache; L Moyroud; L Goirand; O Epaulard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-11       Impact factor: 3.267

Review 8.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 9.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France.

Authors:  Lauranne Moyroud; Sarah Hustache; Laurence Goirand; Marianne Hauzanneau; Olivier Epaulard
Journal:  Hum Vaccin Immunother       Date:  2016-12-12       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.